We too reported a significant reduction in co-localisation of TRPM3 with actin in ME/CFS patients compared with HC under control conditions using a novel immunofluorescent technique. This evidence concerns the gene TRPM3 and myalgic encephalomeyelitis/chronic fatigue syndrome.